Researchers discover swine flu vaccine causes narcolepsy

Monday, January 27, 2014 by: L.J. Devon, Staff Writer
Tags: swine flu vaccine, narcolepsy, scientific research

(NaturalNews) A team of Swedish clinicians have clinically linked a 2009 swine flu vaccine to increased risk of narcolepsy in young adults, and a group of Danish researchers now understand how and why.

Pandemrix, an influenza vaccine unleashed in 2009, was widely administered to combat H1N1, or swine flu, in multiple countries. As reports of people experiencing sleep disturbances mounted, the vaccine manufacturer, GlaxoSmithKline, and organizations like the CDC scrambled to isolate the problem. But the manufacturer continues to pander, saying "Further research is needed to determine whether the observed risk is related to the vaccine, environmental effects, genetic factors, other factors or a combination of them."

But now Swedish clinicians are linking GlaxoSmithKline's 2009 Pandemrix vaccine to immune-related neurological diseases, including increased risk of developing narcolepsy in young adults.

Using data from regional vaccination and national health registries that encompassed 61 percent of the Swedish population and seven healthcare regions, the Swedish researchers conducted a population-based prospective cohort study, as they keyed in on the health consequences of the swine flu vaccine.

While an association couldn't directly be made to immune and neurological diseases, the researchers did find a distinct correlation between the vaccination and narcolepsy starting in individuals younger than 20 years of age. The trend grew more steadily in adults between the ages of 21 and 30.

Dr. I. Persson from the Karolinska Institutet, Stockholm, confirms, "The follow-up of Pandemrix vaccinations in a large registry based study in Sweden confirms an increased risk of narcolepsy in children and adolescents, while also providing reassuring results for a large number of other neurological and immune related diseases."

GlaxoSmithKline responsible for hundreds of sleep-deprived, neurologically damaged individuals

Narcolepsy, which is a chronic neurological disorder, is characterized by the brain's inability to regulate normal sleep-wake cycles. People affected do not receive restful, restorative sleep. Without normal sleep patterns, people are more easily stressed during regular day-to-day activities and have a more difficult time remembering.

Pandemrix, manufactured by GlaxoSmithKline, contains an oil-in-water emulsion adjuvant called ASO3. This adjuvant is added to vaccines to accelerate the body's immune response to that vaccine. Pandemrix was not used in the US but was administered to over 31 million people in Europe in its heyday. GlaxoSmithKline received details of over 900 people from 14 countries who were cursed with vaccine-induced narcolepsy. The European Health Protection Agency found that one person out of every 55,000 jabbed with the vaccine developed serious narcolepsy, disabling people's ability to sleep, learn, cope and think.

Since 2010, The CDC has received official reports from the United Kingdom's Health Protection Agency, showing evidence linking Pandemrix to increased diagnoses of narcolepsy in children in England, Scandinavia, Finland and other countries who implemented the vaccine en masse.

Why isn't GlaxoSmithKline being held responsible?

Danish researchers find out how and why the vaccine wreaks its havoc on a person's sleep cycle

The adjuvants in vaccines are designed to accelerate the human immune system. This causes immune cells to attack specific nerve cells in the brain that are responsible for regulating healthy sleep patterns.

Birgitte Rahbek Kornum, senior researcher from the Department of Diagnostics at Glostrup Hospital in Denmark says, "It has long been suspected that narcolepsy is caused by the immune system attacking some specific nerve cells in the brain, thus destroying the brain's ability to regulate the sleep pattern. Our study confirms this suspicion, as we have figured out which cells in the immune system are responsible for the attack."

He continues, "The immune system can become confused when two molecules are very similar. Our studies show that parts of H1N1 are similar to hypocretin, the neuropeptide in the brain that regulates sleep."

"If a person's immune system contains the cells that we have identified as the culprits behind narcolepsy and comes into contact with either H1N1 or the vaccine against H1N1, the immune system's response can become activated and the disorder can develop."

Sources for this article include:

http://www.wiley.com

http://www.theguardian.com

http://www.cdc.gov

http://sciencenordic.com

http://www.ctvnews.ca

http://science.naturalnews.com

http://science.naturalnews.com